愛爾眼科(300015.SZ)子公司擬斥1.9億元參設亮視晨星
格隆匯8月22日丨愛爾眼科(300015.SZ)公佈,為抓住中國醫療產業快速發展的機遇,進行更快、更好的產業佈局,公司全資子公司拉薩亮視創業投資有限公司(“拉薩亮視”)擬以自有資金1.9億元作為有限合夥人投資設立湖南亮視晨星醫療產業管理合夥企業(有限合夥)(“亮視晨星”)(以企業登記機關最終核准的名稱為準)。亮視晨星將主要對眼科醫院、眼視光門診部等進行投資和管理,為公司未來發展儲備更多優質的併購標的。該事項已於2019年8月22日經公司第四屆董事會第四十八次會議審議通過。
湖南亮視晨星醫療產業管理合夥企業(有限合夥)總規模人民幣10億元,其中,前海安星出資人民幣100萬元,興隴信託出資人民幣7.5億元,拉薩亮視出資人民幣1.9億元,銘鴻創投出資人民幣5900萬元。經營範圍:醫院管理、醫院管理諮詢(以企業登記機關核定的經營範圍為準)。
公司投資設立亮視晨星,目的是在公司行業經驗的基礎上充分利用專業投資團隊和融資渠道,通過各種金融工具和手段放大投資能力,加快眼科醫院、眼視光門診部等的擴張步伐,為公司未來發展儲備更多眼科領域的併購標的。
公司此次投資設立亮視晨星,將有助於公司併購整合優質項目,加快全國網絡建設步伐,完善眼科產業鏈佈局,為公司持續、快速、健康發展提供堅實的基礎,加強和鞏固公司在眼科行業的領先地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.